The aim of this network is to coordinate activities to improve in-vitro, ex-vivo and in-vivo testing procedures, methods to characterise drug absorption into affected skin areas, as well as the development of pharmacodynamic surrogate parameters which allow a biopharmaceutical characterisation. The newly founded network is chaired by Barbara Schug. The Dermatopharmacy Network will be present with a workshop at EUFEPS annual conference in spring 2019.